NEW YORK (AdAge.com) -- The Pharmaceutical Research Manufacturers of America released its voluntary code of conduct for the $4 billion direct-to-consumer advertising industry, calling for a better presentation of risk information and Food and Drug Administration pre-approval of all advertising, but falling well short of a mandate on the most serious issues.